- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease
Total 878 results
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
National Institute of Diabetes and Digestive and...CompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States
-
University of AarhusCompleted
-
HBI Solutions Inc.mProbe Inc.Not yet recruitingNAFLD | NASH - Nonalcoholic Steatohepatitis
-
Russian Academy of Medical SciencesFederal State Budgetary Scientific Institution "Federal Research Centre of...UnknownNAFLD | NASH - Nonalcoholic SteatohepatitisRussian Federation
-
Columbia UniversityPfizerWithdrawnNASH (Nonalcoholic Steatohepatitis) | NAFLD (Nonalcoholic Fatty Liver Disease)
-
AdventHealth Translational Research InstituteCompletedNASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver DiseaseUnited States
-
Columbia UniversityThorne Research Inc.WithdrawnNASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver Disease
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingFibrosis | Cirrhosis | NAFLD | NASH - Nonalcoholic Steatohepatitis | NASH
-
Stefania BasiliUniversity of Roma La SapienzaRecruitingNAFLD | NASH - Nonalcoholic SteatohepatitisItaly
-
University of AarhusCompletedNASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver DiseaseDenmark
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR); McGill University Health Centre... and other collaboratorsRecruitingNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)Canada
-
AstraZenecaCompletedNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | NASH | Fatty Liver, NonalcoholicUnited States
-
Massachusetts General HospitalRecruitingNAFLD | NASH - Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Cairo UniversityElsahel teaching hospitalCompletedNAFLD | NASH - Nonalcoholic SteatohepatitisEgypt
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
Regeneron PharmaceuticalsNot yet recruitingNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD) | Genetic Risk Factor
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsActive, not recruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverUnited Kingdom, Finland, Sweden, Spain, Greece, United States, Switzerland, Italy, France, Germany
-
Duke UniversityCompletedLiver Diseases | Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Milton S. Hershey Medical CenterNot yet recruitingLiver Diseases | NASH - Nonalcoholic Steatohepatitis | NASH
-
Milton S. Hershey Medical CenterRecruitingExercise | NASH - Nonalcoholic Steatohepatitis | NASH | LiverUnited States
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNAFLD | Nonalcoholic Steatohepatitis (NASH) | Fibrosis, LiverUnited States, France, Mexico
-
Merck Sharp & Dohme LLCRecruitingNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, NonalcoholicCanada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo...
-
Hepion Pharmaceuticals, Inc.CompletedFibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Fatty liver FoundationCompletedFatty Liver | NAFLD | NASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States
-
Polaris GroupRecruiting
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
PerspectumRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Metacrine, Inc.Completed
-
Cascade Pharmaceuticals, IncLaboratory Corporation of AmericaCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
RWTH Aachen UniversityCompletedNASH - Nonalcoholic SteatohepatitisSweden, Austria, Germany
-
CymaBay Therapeutics, Inc.TerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Al-Azhar UniversityActive, not recruitingNASH - Nonalcoholic SteatohepatitisEgypt
-
Lipocine Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
Enanta Pharmaceuticals, IncCovanceCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
University of California, Los AngelesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingNAFLD | NASH - Nonalcoholic SteatohepatitisUnited States
-
Guangdong Raynovent Biotech Co., LtdRecruitingNonalcoholic Steatohepatitis (NASH)China
-
Massachusetts General HospitalRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Lipocine Inc.CompletedNonalcoholic Steatohepatitis (NASH)United States
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
CytoDyn, Inc.Amarex Clinical ResearchCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Sinew Pharma Inc.TerminatedNASH - Nonalcoholic SteatohepatitisTaiwan
-
Meridian Bioscience, Inc.Bristol-Myers SquibbCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Altimmune, Inc.Completed
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States